Study shows Pycnogenol effective against post-spider vein treatment skin discoloration



The new study, published in Minerva Surgery​​, indicated that Pycnogenol may provide cosmetics and personal care product manufacturers with a novel, scientifically backed ingredient to incorporate into their formulations to address skin discoloration and related conditions.

The study investigated the effects of Pycnogenol on post-sclerotherapy hyperpigmentation, a cosmetic side effect that occurs in some patients. Franziska Weichmann, Manager of Scientific Communications and Product Development at Horphag Research, the exclusive worldwide supplier of Pycnogenol, explained, “The aim of this study was to evaluate the effects of the oral supplement Pycnogenol on possible skin discolorations or other minor skin changes after compression sclerotherapy (CS) in comparison with standard management.”

Study design and methodology

The study involved 161 healthy women who underwent CS to treat spider veins, which works by injecting a sclerosing agent into the vein, causing the walls to seal shut and stopping blood flow. While the procedure is minimally invasive, it often results in cosmetic side effects like skin discoloration.

Participants were split into two groups. In one group, consisting of 84 participants, ““Pycnogenol was administered in three 50 mg capsules, starting the day before sclerotherapy and continuing for 12 weeks,” said Weichmann. The control group of 77 participants “received standard management without additional drugs,” Weichmann continued, and skin discoloration was measured using an analogue scale for the same time period. 



Source link

Scroll to Top